162 related articles for article (PubMed ID: 38319288)
21. Combination of IFNγ and chemotherapeutic agents increase TRAIL sensitivity of neuroblastoma cell lines.
Tong HX; Lu CW; Wang QS; Ma LY
Eur J Pediatr Surg; 2011 Oct; 21(5):304-9. PubMed ID: 21751122
[TBL] [Abstract][Full Text] [Related]
22. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
[TBL] [Abstract][Full Text] [Related]
23. cFLIP protein prevents tumor necrosis factor-alpha-mediated induction of caspase-8-dependent apoptosis in insulin-secreting betaTc-Tet cells.
Cottet S; Dupraz P; Hamburger F; Dolci W; Jaquet M; Thorens B
Diabetes; 2002 Jun; 51(6):1805-14. PubMed ID: 12031968
[TBL] [Abstract][Full Text] [Related]
24. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH
Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316
[TBL] [Abstract][Full Text] [Related]
25. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis).
Sharma BR; Karki R; Rajesh Y; Kanneganti TD
J Biol Chem; 2023 Sep; 299(9):105141. PubMed ID: 37557956
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated transfection of caspase-8 sensitizes hepatocellular carcinoma to TRAIL- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Nakano T
Biochim Biophys Acta; 2006 Aug; 1763(8):844-53. PubMed ID: 16750275
[TBL] [Abstract][Full Text] [Related]
27. Autophagy genes in myeloid cells counteract IFNγ-induced TNF-mediated cell death and fatal TNF-induced shock.
Orvedahl A; McAllaster MR; Sansone A; Dunlap BF; Desai C; Wang YT; Balce DR; Luke CJ; Lee S; Orchard RC; Artyomov MN; Handley SA; Doench JG; Silverman GA; Virgin HW
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16497-16506. PubMed ID: 31346084
[TBL] [Abstract][Full Text] [Related]
28. Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells.
Chung IJ; Dai C; Krantz SB
Blood; 2003 Feb; 101(4):1324-8. PubMed ID: 12393527
[TBL] [Abstract][Full Text] [Related]
29. Cell Death Inhibiting RNA (CDIR) modulates IFN-gamma-stimulated sensitization to Fas/CD95/Apo-1 and TRAIL/Apo-2L-induced apoptosis.
Shchors K; Yehiely F; Deiss LP
Cell Cycle; 2004 Dec; 3(12):1606-11. PubMed ID: 15611657
[TBL] [Abstract][Full Text] [Related]
30. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis.
Günther C; Martini E; Wittkopf N; Amann K; Weigmann B; Neumann H; Waldner MJ; Hedrick SM; Tenzer S; Neurath MF; Becker C
Nature; 2011 Sep; 477(7364):335-9. PubMed ID: 21921917
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
32. Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways.
Tanzer MC; Khan N; Rickard JA; Etemadi N; Lalaoui N; Spall SK; Hildebrand JM; Segal D; Miasari M; Chau D; Wong WL; McKinlay M; Chunduru SK; Benetatos CA; Condon SM; Vince JE; Herold MJ; Silke J
Cell Death Differ; 2017 Mar; 24(3):481-491. PubMed ID: 28106882
[TBL] [Abstract][Full Text] [Related]
33. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.
Garcia-Diaz A; Shin DS; Moreno BH; Saco J; Escuin-Ordinas H; Rodriguez GA; Zaretsky JM; Sun L; Hugo W; Wang X; Parisi G; Saus CP; Torrejon DY; Graeber TG; Comin-Anduix B; Hu-Lieskovan S; Damoiseaux R; Lo RS; Ribas A
Cell Rep; 2017 May; 19(6):1189-1201. PubMed ID: 28494868
[TBL] [Abstract][Full Text] [Related]
34. Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1.
Luo XM; Ross AC
J Biol Chem; 2005 Oct; 280(43):36228-36. PubMed ID: 16085646
[TBL] [Abstract][Full Text] [Related]
35. SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis.
Yokoyama S; Takahashi A; Kikuchi R; Nishibu S; Lo JA; Hejna M; Moon WM; Kato S; Zhou Y; Hodi FS; Song JS; Sakurai H; Fisher DE; Hayakawa Y
Cancer Res; 2021 Dec; 81(24):6131-6141. PubMed ID: 34728538
[TBL] [Abstract][Full Text] [Related]
36. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
37. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells].
Tong HX; Zhang JH; Ma L; Lu CW; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):327-30. PubMed ID: 16923369
[TBL] [Abstract][Full Text] [Related]
38. Caspase 8 inhibits programmed necrosis by processing CYLD.
O'Donnell MA; Perez-Jimenez E; Oberst A; Ng A; Massoumi R; Xavier R; Green DR; Ting AT
Nat Cell Biol; 2011 Oct; 13(12):1437-42. PubMed ID: 22037414
[TBL] [Abstract][Full Text] [Related]
39. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
Vredevoogd DW; Kuilman T; Ligtenberg MA; Boshuizen J; Stecker KE; de Bruijn B; Krijgsman O; Huang X; Kenski JCN; Lacroix R; Mezzadra R; Gomez-Eerland R; Yildiz M; Dagidir I; Apriamashvili G; Zandhuis N; van der Noort V; Visser NL; Blank CU; Altelaar M; Schumacher TN; Peeper DS
Cell; 2019 Jul; 178(3):585-599.e15. PubMed ID: 31303383
[TBL] [Abstract][Full Text] [Related]
40. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
